The study evaluated the long term effectiveness of a multi-faceted VTE prevention program, consisting of a risk assessment linked to a menu of VTE prophylaxis options (within order entry templates), coupled with education, audit/feedback, and identification of non-adherence. Within 3 years, rates of adequate prophylaxis increased from 58% to 93%, and the risk of hospitalized VTE significantly decreased (RR=0.69, CI 0.47-0.79). Using standard QI methodology, this VTE reduction program is both effective and generalizable (abstract).
I am coming up on my two year anniversary. Not my wedding anniversary (soon to be 15 years – thanks Maia!), but two years since I joined the ranks of the patients. It was two years ago this week that my day was interrupted by a page from my internist saying, “I don’t know how […]
As you can see, no glamour shots for this month’s post. I knew it would come at some point, and my first hospitalization related to my CLL came in a big way in mid-July. Given my interest in global health, it was only fitting that I managed to get sick while out of the […]
This large multicenter trial randomized patients with acute VTE to apixaban (10mg BID for 1 week, followed by 5mg BID for 6 months) versus conventional therapy (lovenox-warfarin). The primary outcome was similar between groups (symptomatic VTE or death related to VTE), but major and minor bleeding occurred significantly less often with apixaban. Apixaban is a […]